Your browser doesn't support javascript.
loading
Very Long-Term Complete Remission Can Be Achieved in Men With High-Risk Localized Prostate Cancer and a Very High PSA Value: An Analysis of the GETUG 12 Phase 3 Trial.
Orlando, Valentina; Drubay, Damien; Lavaud, Pernelle; Faivre, Laura; Lesaunier, François; Delva, Remy; Gravis, Gwenaëlle; Rolland, Frédéric; Priou, Frank; Ferrero, Jean-Marc; Houede, Nadine; Mourey, Loic; Theodore, Christine; Krakowski, Ivan; Berdah, Jean-François; Baciuchka, Marjorie; Laguerre, Brigitte; Fléchon, Aude; Grosse-Goupil, Marine; Cojean-Zelek, Isabelle; Oudard, Stéphane; Labourey, Jean-Luc; Chinet-Charrot, Paule; Legouffe, Eric; Lagrange, Jean-Léon; Linassier, Claude; Deplanque, Gaël; Beuzeboc, Philippe; Davin, Jean-Louis; Martin, Anne-Laure; Brihoum, Meryem; Culine, Stéphane; Teuff, Gwénaël Le; Fizazi, Karim.
Afiliação
  • Orlando V; Department of Oncology, Ospedale Maggiore, Trieste, Italy. Electronic address: valentina.orlando@asugi.sanita.fvg.it.
  • Drubay D; Department of Biostatistics and Epidemiology, Gustave Roussy, University Paris-Saclay, Villejuif, France; Oncostat U1018, Inserm, University Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif, France.
  • Lavaud P; Department of cancer medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France.
  • Faivre L; Department of Biostatistics and Epidemiology, Gustave Roussy, University Paris-Saclay, Villejuif, France.
  • Lesaunier F; Département Médico-technique, Centre François Baclesse, Caen, France.
  • Delva R; Institut de Cancérologie de l'Ouest, Angers, France.
  • Gravis G; Department of Medical Oncology, Institut Paoli Calmettes, Marseille, France.
  • Rolland F; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France.
  • Priou F; Department of Medical Oncology, Centre Hospitalier Départemental, La Roche-sur-Yon, France.
  • Ferrero JM; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France.
  • Houede N; Department of Medical Oncology, Centre Hospitalier de Nimes, Nimes, France.
  • Mourey L; Department of Medical Oncology, Institut Claudius Regaud, Toulouse, France.
  • Theodore C; Department of Medical Oncology, Hôpital Foch, Paris, France.
  • Krakowski I; Department of Medical Oncology, Centre Alexis Vautrin, Nancy, France.
  • Berdah JF; Department of Medical Oncology, Castelluccio Hospital, Ajaccio, France.
  • Baciuchka M; Multidisciplinary Oncology and Therapeutic Innovations Department, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.
  • Laguerre B; Department of Medical Oncology, Centre Eugène Marquis, Rennes, France.
  • Fléchon A; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Grosse-Goupil M; Department of Medical Oncology, Hôpital Saint-André, Bordeaux, France.
  • Cojean-Zelek I; Department of Medical Oncology, Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France.
  • Oudard S; Department of Medical Oncology, Hôpital Européen Georges Pompidou, Paris, France.
  • Labourey JL; Department of Oncology, Hôpital de Carcassonne, Carcasonne, France.
  • Chinet-Charrot P; Department of Oncology, Centre Henri Becquerel, Rouen, France.
  • Legouffe E; Department of Medical Oncology, Clinique Valdegour, Nîmes, France.
  • Lagrange JL; Department of Radiation Oncology, Hopital Henri Mondor, Université Paris Est Creteil, Créteil, France.
  • Linassier C; Department of Medical Oncology, Hôpital Bretonneau, Tours, France.
  • Deplanque G; Department of Oncology, Lausanne University Hospital, Lausanne, Swiss.
  • Beuzeboc P; Oncology and Supportive Care Department, Foch Hospital, Suresnes, France.
  • Davin JL; Clinique Sainte-Catherine, Avignon, France.
  • Martin AL; Unicancer, Paris, France.
  • Brihoum M; Unicancer, Paris, France.
  • Culine S; Department of Medical Oncology, Hôpital Saint-Louis, Paris, France.
  • Teuff GL; Department of Biostatistics and Epidemiology, Gustave Roussy, University Paris-Saclay, Villejuif, France; Oncostat U1018, Inserm, University Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif, France.
  • Fizazi K; Department of cancer medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France.
Clin Genitourin Cancer ; 21(5): 615.e1-615.e8, 2023 10.
Article em En | MEDLINE | ID: mdl-37263910
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: Clin Genitourin Cancer Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: Clin Genitourin Cancer Ano de publicação: 2023 Tipo de documento: Article